Veritas Capital

Veritas Capital
Name	Veritas Capital
Type	Private
Industry	Private equity
Founded	1992
Founder	Robert Smith
Headquarters	Greenwich, Connecticut
Products	Buyouts, growth capital, corporate divestitures

Veritas Capital is a private equity firm headquartered in Greenwich, Connecticut that specializes in acquiring companies in sectors closely tied to United States Department of Defense, United States Department of Health and Human Services, and other United States federal government-adjacent markets. The firm focuses on companies providing mission-critical services and technology, often pursuing carve-outs from large corporations such as Booz Allen Hamilton, General Electric, and Thales Group. Veritas Capital has participated in high-profile transactions involving contractors, healthcare services, and information technology firms, and is known for its operationally intensive approach and activist-style restructuring.

History

Veritas Capital was founded in 1992 by Robert Smith, a financier who previously worked at Goldman Sachs and Salomon Brothers. In the 1990s the firm pursued acquisitions of defense-related firms during post-Cold War consolidation that included targets previously owned by Lockheed Martin, Northrop Grumman, and Raytheon Technologies. During the 2000s and 2010s Veritas executed leveraged buyouts and carve-outs from conglomerates such as Unisys, Tyco International, and ITT Corporation, expanding into healthcare assets spun out of General Electric and Siemens. The firm raised successive private equity vehicles drawing commitments from institutional investors including Pension funds, Sovereign wealth funds and Endowments. Veritas completed notable exits through sales to strategic buyers including Thoma Bravo, Kohlberg Kravis Roberts, and Carlyle Group.

Investment Strategy and Sectors

Veritas emphasizes acquisitions of companies operating in sectors with significant United States federal government spending and regulatory complexity, including defense, intelligence, and healthcare. The firm's strategy frequently targets carve-outs from multinational corporations such as General Electric and Booz Allen Hamilton that lack strategic fit, and it deploys operational improvement programs influenced by private equity practices pioneered at firms like Bain Capital and The Blackstone Group. Veritas often invests in companies providing information technology services, cybersecurity offerings, and managed services used by agencies like the National Aeronautics and Space Administration and Department of Homeland Security. In healthcare, Veritas has acquired firms engaged in revenue cycle management and health information technology previously owned by McKesson Corporation, Cerner Corporation, and Siemens Healthineers.

Notable Acquisitions and Portfolio Companies

Veritas’s portfolio has included transactions involving widely recognized firms and assets. The firm acquired the defense and intelligence businesses of DXC Technology and purchased healthcare units from General Electric including assets once part of GE Healthcare; other investments included the acquisition of Allscripts-related assets and revenue cycle platforms previously held by McKesson. Veritas completed deals for contractors and service providers such as L3Harris Technologies carve-outs, assets linked to Booz Allen Hamilton spin-outs, and technology businesses once part of Thales Group and Siemens. Exits and sales involved purchasers such as Thoma Bravo, KKR, and Warburg Pincus. Veritas has also invested in companies selling software and services to agencies including National Security Agency, Federal Aviation Administration, and Department of Veterans Affairs.

Leadership and Organizational Structure

Founding partner Robert Smith steered Veritas in its early decades; subsequent senior leaders have included executives with backgrounds at Goldman Sachs, Morgan Stanley, and Citigroup. The firm recruits operating partners with experience from contractors and healthcare providers such as Lockheed Martin, Northrop Grumman, Booz Allen Hamilton, and McKesson Corporation to lead portfolio transformations. Veritas maintains offices in Greenwich and other financial centers frequented by firms like BlackRock and Apollo Global Management, and organizes investment teams by sector—defense, intelligence, healthcare, and technology—mirroring structures at CVC Capital Partners and TPG Capital.

Financial Performance and Fundraising

Veritas has raised multiple funds with aggregate capital commitments comparable to peers including The Carlyle Group and The Blackstone Group for niche sector strategies. Its fundraising cycles drew institutional limited partners such as California Public Employees' Retirement System, New York State Common Retirement Fund, and international sovereign entities similar to Abu Dhabi Investment Authority and Qatar Investment Authority. Veritas’s realized returns hinge on exits to strategic buyers like Thoma Bravo and secondary sales to firms like KKR, and the firm has reported strong internal rates of return on several transactions typical of mid-market private equity outcomes. Fund sizes and performance metrics have followed patterns seen across the private equity industry during the 2000s, 2010s, and early 2020s.

Controversies and Legal Issues

Veritas has faced scrutiny and legal challenges common to private equity firms engaged in government contracting and healthcare consolidation. Transactions involving assets from General Electric and Unisys attracted attention from regulatory bodies such as the Federal Trade Commission and agencies overseeing procurement at Department of Defense components. Some portfolio companies were subject to investigations related to contract performance and billing practices that involved interactions with Department of Veterans Affairs and Centers for Medicare & Medicaid Services. Veritas has also navigated disputes with sellers and creditors similar to litigation faced by peers including Apollo Global Management and Carlyle Group, and has engaged in settlement negotiations and compliance enhancements to address regulatory concerns.

Category:Private equity firms Category:Companies based in Connecticut